Abstract
Background:
There are limited data regarding treatment options for pregnant women with severe coronavirus disease 2019 (COVID-19).
Case:
A 35-year-old primigravid patient at 22 weeks of gestation presented with 7 days of fever, cough, anosmia, and dyspnea. Nasopharyngeal swab was positive for the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and a chest X-ray demonstrated bilateral patchy infiltrates. Laboratory evaluation was notable for marked elevation of interleukin-6 and C-reactive protein concentrations. On hospital day 3, owing to increased dyspnea and oxygen requirement, the patient was treated with tocilizumab followed by 5 days of remdesivir. She responded well, recovered to room air, and was discharged home after a 9-day hospitalization.
Conclusion:
Tocilizumab and remdesivir may be effective for treatment of severe COVID-19 in pregnancy, but additional data are needed to guide risk-benefit considerations.
MeSH terms
-
Adenosine Monophosphate / administration & dosage
-
Adenosine Monophosphate / analogs & derivatives*
-
Adult
-
Alanine / administration & dosage
-
Alanine / analogs & derivatives*
-
Antibodies, Monoclonal, Humanized / administration & dosage*
-
Antiviral Agents / administration & dosage
-
Betacoronavirus / isolation & purification
-
C-Reactive Protein / analysis
-
COVID-19
-
COVID-19 Drug Treatment
-
Coronavirus Infections* / blood
-
Coronavirus Infections* / diagnosis
-
Coronavirus Infections* / drug therapy
-
Coronavirus Infections* / physiopathology
-
Female
-
Humans
-
Interleukin-6 / blood
-
Lung / diagnostic imaging*
-
Oximetry / methods
-
Pandemics*
-
Pneumonia, Viral* / blood
-
Pneumonia, Viral* / diagnosis
-
Pneumonia, Viral* / drug therapy
-
Pneumonia, Viral* / etiology
-
Pneumonia, Viral* / physiopathology
-
Pregnancy
-
Pregnancy Complications, Infectious* / blood
-
Pregnancy Complications, Infectious* / diagnosis
-
Pregnancy Complications, Infectious* / drug therapy
-
Radiography, Thoracic / methods
-
SARS-CoV-2
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal, Humanized
-
Antiviral Agents
-
Interleukin-6
-
remdesivir
-
Adenosine Monophosphate
-
C-Reactive Protein
-
tocilizumab
-
Alanine